The more symptoms the better? Covid-19 vaccine side effects and long-term neutralizing antibody response

No abstract is available for this paper.

• Publication year

  2023

• Venue

  medRxiv

• Publication date

  2023-09-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1101/2023.09.26.23296186PMID 37808819PMCID PMC10557821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study

  2023influential reference
• Understanding low COVID-19 booster uptake among US adults.

  2023cited by this paper
• Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination

  2023cited by this paper
• Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study

  2023cited by this paper
• Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022

  2023cited by this paper
• SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination

  2023cited by this paper
• Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022

  2023cited by this paper
• Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers

  2022cited by this paper
• Metrics from Wearable Devices as Candidate Predictors of Antibody Response Following Vaccination against COVID-19: Data from the Second TemPredict Study

  2022cited by this paper
• Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine

  2022cited by this paper
• Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

  2022cited by this paper
• Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

  2022cited by this paper
• SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

  2022cited by this paper
• Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines

  2022cited by this paper
• Association of Symptoms After COVID-19 Vaccination With Anti–SARS-CoV-2 Antibody Response in the Framingham Heart Study

  2022cited by this paper
• Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations

  2022cited by this paper
• T Cell Responses to SARS-CoV-2.

  2022cited by this paper
• Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

  2021cited by this paper
• Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

  2021influential reference
• Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers

  2021cited by this paper
• Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

  2021cited by this paper
• Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.

  2021cited by this paper
• Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines

  2021cited by this paper
• Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis

  2021influential reference
• Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

  2021cited by this paper
• Significant

  2020cited by this paper
• The Accuracy of Wrist Skin Temperature in Detecting Ovulation Compared to Basal Body Temperature: Prospective Comparative Diagnostic Accuracy Study

  2020cited by this paper
• Feasible assessment of recovery and cardiovascular health: accuracy of nocturnal HR and HRV assessed via ring PPG in comparison to medical grade ECG

  2020cited by this paper
• Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

  2020cited by this paper
• Nocturnal finger skin temperature in menstrual cycle tracking: ambulatory pilot study using a wearable Oura ring

  2019cited by this paper
• Modern fertility awareness methods: wrist wearables capture the changes in temperature associated with the menstrual cycle

  2017cited by this paper
• A Meta-Analysis

  2009cited by this paper
• ANOVA for unbalanced data: Use Type II instead of Type III sums of squares

  2003cited by this paper
• Measurements

  1996cited by this paper
• : a prospective observational study

  year unknowncited by this paper

• Health as Goal? AnAttempt at an Overview

  2024cites this paper
• The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review

  2023cites this paper